ClinicalTrials.gov
ClinicalTrials.gov Menu

Electrical Impedance Tomography of Lung in Child and Young Age (EIT-Lunge)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02290535
Recruitment Status : Completed
First Posted : November 14, 2014
Last Update Posted : July 16, 2015
Sponsor:
Information provided by (Responsible Party):
RWTH Aachen University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The investigator will determine a compliance of two diagnostic techniques (EIT and Body plethysmography) in collective of children and teenagers with obstructive lung disease and a matched control group.

Condition or disease Intervention/treatment
Obstructive Lung Diseases Procedure: patients Procedure: probands

Detailed Description:

The aim of the present study is verification of the correlation between EIT-derived data and following extracted parameters of the pulmonary function:

  • forced expiratory volume in 1 second (FEV 1)
  • forced vital capacity (FVC)
  • relative forced expiratory volume in 1 second (FEV1/FVC)
  • maximal expiratory flow (MEF 25)
  • total lung capacity (TLC)
  • resistance (Raw).

These findings could bring out new prospective opportunity for pulmonary function tests without cooperation.

Furthermore, the study aims to clarify whether EIT technique can be used for regional pulmonary function testing.

In addition, dynamic lung function parameter and static radiological techniques will be correlated with EIT.


Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 192 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Electrical Impedance Tomography of Lung in Child and Young Age
Study Start Date : June 2014
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Diseases

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Patients
Children and Teenager of 5-18 years with obstructive pulmonary disease (asthma, cystic fibrosis, immotile-cilia-syndrome, obstructive bronchitis, obstructive pneumonia).
 Procedure: patients
The 16-electrode belt will be applied to patient's chest. Following vital signs will be recorded: respiratory rate at rest breathing, heart rate, transcutaneous oxygen saturation. Then impulse oscillometry (IOS) will be performed in a sitting position. After that, subjects with cooperation willingness will get a body plethysmography. A spirometry / forced breathing maneuvers will be performed. All patients will receive 2 strokes salbutamol inhaler for bronchospasmolysis. Please note that inhalation of salbutamol is not study related. It is used in the clinical routine to examine the reversibility of the bronchial obstruction in patients with obstructive lung disease in course of the lung function test. Ten minutes later measurements described above will be repeated.
Probands
Children and Teenager of 5-18 years without known obstructive pulmonary diseases
 Procedure: probands
Probands will receive the same treatment as patients, but without bronchospasmolysis.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Robustness of change in electrical impedance based on the forced expiratory volume in 1 second (ΔZFEV01) [ Time Frame: Baseline ]
    The robustness of ΔZFEV1.0 (= change in electrical impedance based on the FVC FEV1.0) and τ (= mechanical time constant τ which classifies the regional and global lung mechanics) and their clinical relevance will be investigated.


Secondary Outcome Measures :
  1. Correlation between lung function parameters and extracted parameters of the EIT. [ Time Frame: Baseline ]
    The present study aims to verify, whether a correlation between lung function parameters and extracted parameters of the EIT exists.

  2. EIT as a diagnostic method for assessment of lung function [ Time Frame: Baseline ]
    It will be examined, whether single EIT measurement can be used for assessment of the lung function.

  3. Regional mechanical transmission behavior [ Time Frame: Baseline ]
    Another secondary outcome is the local mechanical transmission behavior as an index of pulmonary status. By using the correlation between results gained from EIT and results from impulse oscillometry (IOS) differentiation between central and peripheral obstruction of respiratory tracts will be proved.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients, who come to the consultation to the Department of Pediatric Pneumology, Children and Adolescent Medicine, University Hospital Aachen, will be recruited and divided into groups by age and diagnosis. Recriutment will be performed in accordance to the inclusion and exclusion criteria.
Criteria

Inclusion Criteria:

  • Patients: children and teenagers with obstructive pulmonary disease (asthma, cystic fibrosis, immotile-cilia-syndrome, obstructive brochitis, obstructive pneumonia).
  • Probands: Children and Teenager of 5-18 years without known obstructive pulmonary diseases

Exclusion Criteria:

  • active implants (ICD, CRT)
  • metal in chest
  • artificial heart valve
  • children < 5 years
  • pregnant and lactating females
  • Persons, who are in relationship of dependence to the investigator / sponsor
  • Persons, who are not able to understand and follow the instructions of the study personnel.
  • Lack of signed informed consent (by legal guardian /proband)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02290535


Locations
Germany
University Hospital Aachen
Aachen, NRW, Germany, 52074
Sponsors and Collaborators
RWTH Aachen University
Investigators
Principal Investigator: Sylvia Lehmann, MD Unversity Hospital Aachen
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: RWTH Aachen University
ClinicalTrials.gov Identifier: NCT02290535     History of Changes
Other Study ID Numbers: 12-076
CIV-14-03-011942 ( Other Identifier: Eudamed-Nr. )
First Posted: November 14, 2014    Key Record Dates
Last Update Posted: July 16, 2015
Last Verified: July 2015

Keywords provided by RWTH Aachen University:
obstructive pulmonary disease
children
teenager
EIT (Electrical Impedance Tomography)

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases